- 방사선종양학과
- 전완 주임과장
- 진료분야
- 전립선암, 직장암, 간담도췌장암, 방광암, 신장암, 위암, 전이암
- 진료일정
- 4월
- 진료
- 휴진
진료과 사정에 따라 인터넷 예약이 불가한 의사도 있습니다.
진료예약
학력/경력
학력
- 서울대학교 의학과 박사 (방사선종양학)
- 전남대학교 의학과 석사 (방사선종양학)
- 전남대학교 의학과 학사
경력
- 2021년 - 현재 동남권원자력의학원 원자력병원 방사선종양학과 주임과장
- 2018년 - 현재 동남권원자력의학원 원자력병원 방사선종양학과 과장
- 2016년 - 2018년 서울대학교병원 전임의
- 2013년 - 2016년 공중보건의사
- 2012년 - 2012년 The University of Texas Southwestern Medical Center, Department of Radiation Oncology 단기연수
- 2009년 - 2013년 서울대학교병원 전공의
- 2008년 - 2009년 서울대학교병원 수련의
주요활동
- 유럽방사선종양학회 (ESTRO)
- 미국방사선종양학회 (ASTRO)
- 대한방사선방어학회
- 대한방사선종양학회
수상이력
- 2017 [2017 Poster Award, The Korean association for Radiation Protection] Preliminary Application of Synt
연구업적
- The prognostic value of the nodal ratio in N1 breast cancer. Han TJ, Kang EY, Jeon W, Kim SW, Kim JH, Kim YJ, Park SY, Kim JS, Kim IA. Radiat Oncol. 2011 Oct 6;6:131.
- Salvage radiotherapy for lymph node recurrence after radical surgery in cervical cancer. Jeon W, Koh HK, Kim HJ, Wu HG, Kim JH, Chung HH. J Gynecol Oncol. 2012 Jul;23(3):168-74.
- Radial displacement of clinical target volume in node negative head and neck cancer. Jeon W, Wu HG, Song SH, Kim JI. Radiat Oncol J. 2012 Mar;30(1):36-42.
- Outcome analysis of salvage radiotherapy for occult cervical cancer found after simple hysterectomy. Koh HK, Jeon W, Kim HJ, Wu HG, Kim K, Chie EK, Ha SW. Jpn J Clin Oncol. 2013 Dec;43(12):1226-32.
- Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy. Chang JH, Jeon W, Kim K, Shin KH, Han W, Noh DY, Im SA, Kim TY, Bang YJ. J Breast Cancer. 2016 Dec;19(4):394-401.
- Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study. Jeon W, Ahn SJ, Kim YC, Oh IJ, Park CK, Jeong JU, Yoon MS, Song JY, Nam TK, Chung WK Jpn J Clin Oncol. 2018 Feb 1;48(2):144-152.
- Analysis of Survival Outcomes based on Molecular Subtypes in Breast Cancer Brain Metastases: A Single Institutional Cohort. Jeon W, Jang BS, Jeon SH, Kim JH, Kim YJ, Kim SH, Kim CY, Han JH, Kim IA. Breast J. 2018 Nov;24(6):920-926.
- A Case of Achieving Partial Remission with the Combination of Sorafenib and Nivolumab in a Patient with Hepatocellular Carcinoma Showing Disease Progression after Nivolumab Therapy. Hwang SY , Lee SM , Im JW , Jeon KJ , Choi CW , Kim KS , Jeon W. Journal of Liver Cancer. 2019 Mar;19(1):74-78.
- Preliminary Application of Synthetic Computed Tomography Image Generation from Magnetic Resonance Image Using Deep-Learning in Breast Cancer Patients Jeon W, An HJ, Kim JI, Park JM, Kim HN, Shin KH, Chie EK. Journal of Radiation Protection and Research 2019;44(4):149–155
- Treatment time to the end of thoracic radiotherapy has more predictive power for survival than radiation dose intensity in patients with limited‑stage small‑cell lung cancer receiving concurrent chemoradiation of more than 45 Gy. Jeon W, Jeong JU, Ahn SJ, Kim YC, Oh IJ, Park CK, Yoon MS, Song JY, Nam TK, Chung WK. Oncol Lett. 2020 Jan;19(1):239-246.
- Which Is Better for Liver SBRT: Dosimetric Comparison Between DCAT and VMAT for Liver Tumors. Moon YM, Jeon W, Yu T, Bae SI, Kim JY, Kang JK, Choi CW. Front Oncol. 2020 Jul 29;10:1170.
- Evaluation of monoxide film-based dosimeters for surface dose detection in electron therapy. Han MJ, Yang SW, Bae SI, Moon YM, Jeon W, Choi CW, Park SK, Kim JY. PLoS One. 2021 May 21;16(5).
- Correlation Between Average Segment Width and Gamma Passing Rate as a Function of MLC Position Error in Volumetric Modulated Arc Therapy. Moon YM, Bae SI, Han MJ, Jeon W, Yu T, Choi CW, Kim JY. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211059937.
- Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation. Jeon W, Jung SY, Lee CY, Kim WT, Kim H, Jang KW, Lim H, Lee M, Jeong DH, Kim SD, Kim IA, Choi SH, Son TG, Kim KS. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231165125
- A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab. Kim HJ, Hwang SY, Im JW, Jeon KJ, Jeon W. J Liver Cancer. 2023 Mar;23(1):213-218.